These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11087658)

  • 1. Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.
    Hoff C; Seranski P; Mollenhauer J; Korn B; Detzel T; Reinhardt R; Ramser J; Poustka A
    Genomics; 2000 Nov; 70(1):26-33. PubMed ID: 11087658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
    Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
    Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
    Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
    Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
    Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
    Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
    Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
    FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
    Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription mapping in a medulloblastoma breakpoint interval and Smith-Magenis syndrome candidate region: identification of 53 transcriptional units and new candidate genes.
    Seranski P; Heiss NS; Dhorne-Pollet S; Radelof U; Korn B; Hennig S; Backes E; Schmidt S; Wiemann S; Schwarz CE; Lehrach H; Poustka A
    Genomics; 1999 Feb; 56(1):1-11. PubMed ID: 10036180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.
    Deltour S; Pinte S; Guérardel C; Leprince D
    Biochem Biophys Res Commun; 2001 Sep; 287(2):427-34. PubMed ID: 11554746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
    Pinte S; Guérardel C; Deltour-Balerdi S; Godwin AK; Leprince D
    Oncogene; 2004 May; 23(22):4023-31. PubMed ID: 15007385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
    Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
    Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.